Our Patients
Keeping Patients Front and Center
Our mission is to deliver effective drugs where they are needed most while increasing therapeutic benefit, lessening side effects and improving quality of life for patients with cancer and other diseases. With the help of participants in our studies, we will be able to offer new treatments to address patients’ unmet needs.
Expanded Access
Ankyra Therapeutics is committed to providing patients with full transparency to our products and policies. Our current policy does not permit expanded access to any drug products since there is no clinical and/or safety data available. We will reconsider our expanded access policy for individual drugs once preliminary safety data is available for full analysis from planned Phase I clinical trials. Please leave any messages at our patient access email at info@ankyratx.com
Selected Patient Resources
Dedicated to saving lives by advancing the discovery and development of cutting-edge immunotherapies to combat all forms of cancer.
Improving cancer patient outcomes by advancing the science and application of cancer immunology and immunotherapy.
Leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.
Improving the lives of cancer patients and their families through advocacy, research, and support, ensuring everyone has the opportunity to prevent, detect, treat, and survive cancer.
Fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.
Core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up.
* These organizations listed do not represent an endorsement or a recommendation from Ankyra.